Cardiovascular Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cardiovascular Disease stocks.

Cardiovascular Disease Stocks Recent News

Date Stock Title
Apr 26 LH Integer Holdings (ITGR) Q1 Earnings Top Estimates, Margins Up
Apr 26 JNJ Are You Looking for a High-Growth Dividend Stock?
Apr 26 LH 3 Medical Products Stocks Set to Beat This Earnings Season
Apr 26 JNJ 5 Stocks in Focus on Their Recent Dividend Hike
Apr 26 LH Laboratory Corporation of America Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Apr 26 LH Q1 2024 Laboratory Corporation of America Holdings Earnings Call
Apr 25 LH Laboratory Corporation of America Holdings (LH) Q1 2024 Earnings Call Transcript
Apr 25 LH Labcorp to acquire Invitae’s assets for $239M
Apr 25 JNJ Cidara buys back rights to flu therapy from J&J for $85m
Apr 25 LH Labcorp (LH) Tops Q1 Earnings Estimates, Raises 2024 EPS View
Apr 25 LH Compared to Estimates, Labcorp (LH) Q1 Earnings: A Look at Key Metrics
Apr 25 BCDA BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
Apr 25 LH Laboratory Corp of America Holdings (LH) Q1 Earnings: Surpasses Revenue Forecasts and Updates ...
Apr 25 JNJ Johnson & Johnson's (NYSE:JNJ) Dividend Will Be Increased To $1.24
Apr 25 LH Laboratory Corporation of America beats Q1 estimates
Apr 25 LH Labcorp Announces 2024 First Quarter Results
Apr 25 LH Labcorp wins bid to acquire select Invitae assets for $239 mln
Apr 25 LH Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 million
Apr 25 LH Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln
Apr 25 LH Labcorp Announces Winning Bid for Select Assets of Invitae
Cardiovascular Disease

Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.The underlying mechanisms vary depending on the disease. Coronary artery disease, stroke, and peripheral artery disease involve atherosclerosis. This may be caused by high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol consumption, among others. High blood pressure results in 13% of CVD deaths, while tobacco results in 9%, diabetes 6%, lack of exercise 6% and obesity 5%. Rheumatic heart disease may follow untreated strep throat.It is estimated that 90% of CVD is preventable. Prevention of atherosclerosis involves improving risk factors through: healthy eating, exercise, avoidance of tobacco smoke and limiting alcohol intake. Treating risk factors, such as high blood pressure, blood lipids and diabetes is also beneficial. Treating people who have strep throat with antibiotics can decrease the risk of rheumatic heart disease. The use of aspirin in people, who are otherwise healthy, is of unclear benefit.Cardiovascular diseases are the leading cause of death globally. This is true in all areas of the world except Africa. Together they resulted in 17.9 million deaths (32.1%) in 2015, up from 12.3 million (25.8%) in 1990. Deaths, at a given age, from CVD are more common and have been increasing in much of the developing world, while rates have declined in most of the developed world since the 1970s. Coronary artery disease and stroke account for 80% of CVD deaths in males and 75% of CVD deaths in females. Most cardiovascular disease affects older adults. In the United States 11% of people between 20 and 40 have CVD, while 37% between 40 and 60, 71% of people between 60 and 80, and 85% of people over 80 have CVD. The average age of death from coronary artery disease in the developed world is around 80 while it is around 68 in the developing world. Disease onset is typically seven to ten years earlier in men as compared to women.

Browse All Tags